
Read More
Kwality Pharmaceuticals Has Returned 238% in One Year. The Bigger Story Is ...
Six manufacturing units, 700-plus regulatory filings, biosimilar clinical trials underway and a reve...

Six manufacturing units, 700-plus regulatory filings, biosimilar clinical trials underway and a reve...

Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue...

Company’s shares jumped after receiving approval from Brazil’s National Health Surveillance Agency f...